This is a notice of intent to award a sole-source, firm fixed-price contract to 10X Genomics Inc. for reagents and consumables needed for the Early Detection of Lung Diseases project. The National Institutes of Health, on behalf of the Critical Care Medicine Department, is conducting this acquisition under simplified acquisition procedures, as only one source is deemed reasonably available. No solicitation document will be issued, and quotations are not being requested. Comments on this announcement may be submitted to the specified contract specialist by the closing date listed in the notice. The location for performance of services is not specified.